Department of Urology, Luzerner Kantonsspital, University of Lucerne, Lucerne, Switzerland; Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy.
Department of Urology, Western General Hospital, Edinburgh, UK.
Eur Urol Focus. 2023 Jul;9(4):631-636. doi: 10.1016/j.euf.2023.01.012. Epub 2023 Jan 27.
Patients undergoing radical cystectomy frequently suffer from infectious complications, including urinary tract infections (UTIs) and surgical site infections (SSIs) leading to emergency department visits, hospital readmission, and added cost.
To summarize the literature regarding perioperative antibiotic prophylaxis, ureteric stent usage, and prevalence of infectious complications after cystectomy.
A systematic review of PubMed/Medline, EMBASE, Cochrane Library, and reference lists was conducted.
We identified 20 reports including a total of 55 306 patients. The median rates of any infection, UTIs, SSIs, and bacteremia were 40%, 20%, 11%, and 6%, respectively. Perioperative antibiotic prophylaxis differed substantially between reports. Perioperative antibiotics were used only during surgery in one study but were continued over several days after surgery in all other studies. Empirical use of antibiotics for 1-3 d after surgery was described in 12 studies, 3-10 d in two studies, and >10 d in four studies. Time to stent removal ranged from 4 to 25 d after cystectomy. Prophylactic antibiotics were used before stent removal in nine of 20 studies; two of these studies used targeted antibiotics based on urine cultures from the ureteric stents, and the other seven studies used a single shot or 2 d of empirical antibiotics. Studies with any prophylactic antibiotic before stent removal found a lower median percentage of positive blood cultures after stent removal than studies without prophylactic antibiotics before stent removal (2% vs 9%).
We confirmed a high proportion of infectious complications after cystectomy, and a heterogeneous pattern of choice and duration of antibiotics during and after surgery or stent removal. These findings highlight a need for further studies and support quality prospective trials.
In this review, we observed wide variability in the use of antibiotics before or after surgical removal of the bladder.
接受根治性膀胱切除术的患者常发生感染性并发症,包括尿路感染(UTI)和手术部位感染(SSI),导致急诊就诊、医院再入院和额外费用。
总结膀胱切除术后围手术期抗生素预防、输尿管支架使用和感染性并发症的发生率相关文献。
对 PubMed/Medline、EMBASE、Cochrane 图书馆和参考文献列表进行了系统评价。
我们共确定了 20 项研究,总计 55306 例患者。任何感染、UTI、SSI 和菌血症的中位发生率分别为 40%、20%、11%和 6%。报告中围手术期抗生素预防措施差异较大。一项研究仅在手术期间使用围手术期抗生素,但所有其他研究均在手术后数天内继续使用。12 项研究描述了术后 1-3 天经验性使用抗生素,2 项研究使用 3-10 天,4 项研究使用>10 天。支架取出后时间范围为膀胱切除术后 4-25 天。20 项研究中有 9 项在支架取出前使用了预防性抗生素;其中两项研究根据输尿管支架的尿液培养使用了靶向抗生素,另外七项研究使用了单次或 2 天的经验性抗生素。在支架取出前使用任何预防性抗生素的研究中,支架取出后血培养阳性的中位百分比低于未在支架取出前使用预防性抗生素的研究(2% vs 9%)。
我们证实了膀胱切除术后感染性并发症的比例较高,并且在手术期间和手术后或支架取出期间选择和使用抗生素的模式存在很大差异。这些发现强调需要进一步研究和支持质量前瞻性试验。
在这项综述中,我们观察到在膀胱切除术后使用抗生素的方式存在很大的差异。